Cetuximab in the treatment of colorectal cancer.Richard M. Goldberg(University of North Carolina at Chapel Hill), Alan P. Venook, Richard L. SchilskyPubMedNovember 1, 2004Cited by 1,517SaveCiteExport RISWatch citationsAbstractRelated PapersSurvival Analysis Techniques for Censored and Truncated DataMarepalli B. Rao, John P. Klein, Melvin L. Moeschberger|Technometrics|1998|3.6kRandomized phase III study of irinotecan and 5-FU/FA with or without cetuximab in the first-line treatment of patients with metastatic colorectal cancer (mCRC): The CRYSTAL trialEric Van Cutsem, Marek P. Nowacki, István Láng et al.|Journal of Clinical Oncology|2007|315Impact on quality of life of adding cetuximab to irinotecan in patients who have failed prior oxaliplatin-based therapy: The EPIC trialCathy Eng, Joan Maurel, Werner Scheithauer et al.|Journal of Clinical Oncology|2007|41